Ventripoint Diagnostics Ltd. formerly Luca Capital Inc. belongs to the Health Care sector. Filings by its managers are published through SEDI. Over the twelve months to 24 October 2026, 21 filings were filed, from 5 insiders.
Both sides are active: 1 purchase worth €1,202 and 2 sales worth €7,442, from 1 insider and 1 insider respectively. Sales outweigh purchases by €6,240. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Among those who bought: 1 senior executive. The largest single trade was a sale of €4,877 by Adams, George, published on 7 February 2026.
The latest purchase dates back some time: it was published 279 days ago, on 18 January 2026. The median gap between a trade and its publication by SEDI is 4 days. This delay matters because a trade only becomes useful information once it is public. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
With 21 filings in twelve months, the company is more active than the median of 14 filings across the 2,685 companies we follow on the same exchange. Over the whole record (from 2010), the tally stands at 29 purchases and 39 sales.
Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2025 · cache
25 of 132 declarations
Ventripoint Diagnostics Ltd., formerly Luca Capital Inc., is a company focused on developing diagnostic solutions for heart diseases. It is listed on the XTSE market.